[关键词]
[摘要]
目的 分析2013-2018年南京大学医学院附属鼓楼医院抑酸药的使用情况及发展趋势。方法 对2013-2018年南京大学医学院附属鼓楼医院抑酸药的用药金额、用药频度(DDDs)、日均费用(DDC)和药品排序比(B/A)进行统计分析。结果 质子泵抑制剂的用药金额远高于H2受体拮抗剂,注射用兰索拉唑、注射用艾司奥美拉唑钠、注射用泮托拉唑钠、注射用奥美拉唑钠和雷贝拉唑钠肠溶片一直稳居用药金额的前5位。奥美拉唑肠溶胶囊和雷贝拉唑钠肠溶片的DDDs稳居前2位,2013-2018年除了西咪替丁注射液的DDC值上升外,其他药品的DDC值都下降。奥美拉唑肠溶胶囊的B/A很高。结论 南京大学医学院附属鼓楼医院抑酸药的使用基本合理,质子泵抑制剂是抑酸药使用的主流。
[Key word]
[Abstract]
Objective To study the use and development trend of acid inhibitors in Drum Tower Hospital Affiliated to Nanjing University Medical School from 2013 to 2018. Methods Consumption sum, defined daily doses (DDDs), defined daily cost (DDC), and drug sequence ratio (B/A) in Drum Tower Hospital Affiliated to Nanjing University Medical School from 2013 to 2018 were analyzed statistically. Results Consumption sum of proton pump inhibitors were far more than those of H2 receptor antagonists. Consumption sums of Lansoprazole for injection, Esomeprazole Sodium for injection, Pantoprazole Sodium for injection, Omeprazole Sodium for injection, and Sodium Rabeprazole Enteric-coated Tablets were consistently ranked the top 5. DDDs of Omeprazole Eenteric-coated Capsules and Rabeprazole Sodium Enteric-coated Tablets were in the top two places. DDC of Cimetidine Injection was increased from 2013 to 2018, but DDC of others were decreased. B/A of Omeprazole Enteric-coated Capsules was high. Conclusion The use of acid inhibitors in Drum Tower Hospital Affiliated to Nanjing University Medical School is basically reasonable. Proton pump inhibitors are the mainstream of acid inhibitors in the hospital.
[中图分类号]
R975
[基金项目]